Phase II Study of Immunization With a Hepatitis C Virus (HCV) Antigen Peptide Vaccine

Clinical trial NCT00602784 · COMPLETED

Trial details

NCT number: NCT00602784
Sponsor: Valneva Austria GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2002-11-01
Primary completion: 2004-05-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.